Leading the Way in Life Science Technologies

GEN Exclusives

More »
Insight & Intelligence™

Related to NIH’s TRND Program Will Boost Rare and Neglected Disease Drug Development, GEN Voters Say

  • Page 1 of 1 (10 items) 1 

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »